TickerFacts.

Company research / ELV

Elevance Health, Inc. (ELV)

Build a valuation ↗↓ Download CSV

CIK 0001156039 · NYSE · Hospital & Medical Service Plans

  • Sector Finance & Real Estate
  • Incorporated IN
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Elevance Health, Inc. reported revenue of $199.12B. Revenue grew 12.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $201.11B.

Key ratios (year ended 2025-12-31)

3.6%
Operating margin
2.8%
Net margin
12.9%
Return on year-end equity
12.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-06

Headquarters locality: Indianapolis · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$201.11B$199.12B$177.01B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B
Cost of Revenue$21.86B$21.18B$19.75B$17.29B$13.04B$10.89B$8.95B$1.99B$0$0n/a
Operating Income$5.45B$7.20B$7.86B$8.50B$8.28B$7.56B$6.36B$6.00B$5.43B$4.17B$4.80B
Depreciation & Amortization$1.51B$1.55B$1.39B$1.75B$1.68B$1.30B$1.15B$1.13B$1.13Bn/an/a
EBITDA$6.97B$8.74B$9.26B$10.24B$9.96B$8.86B$7.51B$7.13B$6.56Bn/an/a
Net Income$4.96B$5.66B$5.98B$5.99B$5.89B$6.16B$4.57B$4.81B$3.75B$3.84B$2.47B
EPS (Diluted)n/a$25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21
Total Assets$126.44B$121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B
Total Liabilities$81.42B$77.47B$75.46B$69.52B$66.42B$61.33B$53.42B$45.73B$43.03B$44.04B$39.98B
Long-Term Debt$31.04B$31.90B$30.87B$24.89B$23.85B$22.76B$20.04B$19.39B$18.07B$18.66B$15.29B
Shareholders' Equity$44.88B$43.88B$41.31B$39.31B$36.24B$36.06B$33.20B$31.73B$28.54B$26.50B$25.10B
Cash & Equivalents$10.23B$9.49B$8.29B$6.53B$7.39B$4.88B$5.74B$4.94B$3.93B$3.61B$4.08B
Operating Cash Flow$7.46B$4.29B$5.81B$8.06B$8.40B$8.36B$10.69B$6.06B$3.83B$4.18B$3.27B
Capital Expenditures$1.18B$1.12B$1.26B$1.30B$1.15B$1.09B$1.02B$1.08B$1.21B$791.00M$584.00M
Free Cash Flow$6.29B$3.17B$4.55B$6.76B$7.25B$7.28B$9.67B$4.98B$2.62B$3.39B$2.69B
Share Repurchases$2.71B$2.60B$2.90B$2.68B$2.32B$1.90B$2.70B$1.70B$1.69B$2.00B$0
Dividends Paid$1.51B$1.53B$1.51B$1.40B$1.23B$1.10B$954.00M$818.00M$776.00M$705.00M$684.00M
Shares Outstanding216.84M220.72M227.48M233.07M237.96M241.77M245.40M252.92M257.40M256.08M263.75M
Dividends Per Sharen/an/an/a$5.92$5.12$4.52$3.80$3.20$3.00$2.70$2.60
Weighted Average Diluted Sharesn/a224.60M232.90M237.40M242.80M246.80M254.30M260.30M264.20M267.80M268.10M
EPS (Basic)n/a$25.28$25.81$25.38$24.56$25.26$18.23$18.81$14.53$14.70$9.39

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView